We are very interested in finding commercial partners to help commercialize our research. Please do not hesitate to contact us to discuss potential partnerships. We are eager to help!
For technical questions, pleast contact Professor Pattichis, telephone: (505) 277-0486, firstname.lastname@example.org or through the official UNM email: email@example.com. However, please note that I am likely to respond using gmail :-).
VisionQuest Biomedical was co-founded by Dr. Simon Barriga in 2008. Dr. Barriga completed his Ph.D. dissertation under Professor Pattichis in 2006. Professor Pattichis served as the Ph.D. dissertation advisor to several former students who worked at VisionQuest Biomedical (e.g., Dr. Yu, Dr. Murray, Dr. Murillo, Dr. Agurto, Dr. Carranza, in addition to Dr. Barriga). In collaboration with Professor Pattichis, VisionQuest Biomedical developed a Computer Aided Diagnostic System to detect diabetic retinopathy, mucular degeneration, and glaucoma. VisionQuest Biomedical received more than $20 million dollars in NIH funding and has applied the system to more than 24,000 patients. Dr. Barriga is currently the CEO of VisionQuest Biomedical.
The collaboration with VisionQuest Biomedical has been extremely productive. Refer to the U.S. Patent 8,515,201 B1 listed below, the AM-FM Representations webpage , and the Eye Image Analysis section of the Biomedical Research page.
3AHealth was co-founded by Dr. Andreas Panayides. Dr. Panayides has been collaborating with Professor M.S. Pattichis since 2005. He has served as an Assistant Director of the Image and Video Processing and Communications Lab between 2015 and 2017 and contributed significantly to the NSF DRASTIC project. Working with Professor M.S. Pattichis, he incorporated diagnostic ROI-encoding methods to significantly reduce the required bandwidth for biomedical ultrasound video communications. At 3AHealth, he is leading the efforts for developing the electronic health records for Cyprus, expected to serve a population of approximately one million patients. Dr. Panayides is currently director of research and development at 3AHealth.
The collaboration with Dr. Panayides has been extremely productive. Refer to DRASTIC webpage, and the Telemedicine and Medical ultrasound video communications sections of the
Biomedical Research page.
The collaboration with Dr. Panayides has been extremely productive. Refer to DRASTIC webpage, and the Telemedicine and Medical ultrasound video communications sections of the Biomedical Research page.
LifeQ Medical was co-founded by Professor A.N. Nicolaides who has been collaborating with Professor M.S. Pattichis. The plaque texture analysis co-developed with Professor M.S. Pattichis is currently in use as a research tool in more than 15 academic departments of hospitals worldwide. Users of the software include: Columbia University, Cambridge University Hospitals, Imperial College, the University of Athens in Greece, and the University of Crete in Greece. Our joint research produced the following invited journal paper that had received a best conference paper award:
Kyriacou, E., Pattichis, M.S., Pattichis, C.S., Mavrommatis, A., Christodoulou, C.I., Kakkos, S. and Nicolaides, A., “Classification of Atherosclerotic Carotid Plaques Using Morphological Analysis on Ultrasound images,” (a best conference paper award) invited in special issue on Emerging Artificial Intelligence Applications and Innovations: Papers from AIAI 2006, Journal of Applied Intelligence, Springer, vol. 30, no. 1, pp. 3-23, February 2009.
For a list of related publications, refer to the Stroke ultrasound image and video analysis section of the Biomedical research webpage.
IDEAS-TEK was co-founded by Dr. Alonzo Vera, 2008 Ph.D. graduate of ivPCL. IDEAS Engineering & Technology (IDEAS-TEK) is a small business dedicated to the development of innovative and cost-effective solutions for the defense and space industry.
Professor M.S. Pattichis was a founding Co-PI of COSMIAC with Professor Christodoulou. Mr. Craig Kief, who graduated with an M.Sc. Thesis under Professor Pattichis, is currently serving as the Director of COSMIAC.
The discrete periodic radon transform can be applied to medical imaging, detecting lines in images, and fast convolution. The patent is now available for licensing.
Dynamic management of software and hardware resources allows joint optimization
of performance, power/energy, accuracy, and bandwidth in image and video processing systems.
Refer to the architectures research projects and the
DRASTIC research project for applications.
Applications include adaptive video communications (including medical video communications),
digital filtering, and adaptive filterbank implementations.
The patent is now available for licensing.
The patent extends the previous AM-FM patent on System and Methods of Amplitude Modulation – Frequency Modulation (AM-FM) Demodulation for Image and Video Processing (U.S. Patent 8,515,201 B1) given below. Details can also be found in:
P. Rodriguez, V. Murray, and M. Pattichis. “ A regularized optimization approach for am-fm reconstructions . In Proc. Asilomar Conference on Signals, Systems and Computers,” pages 219-221, Nov 2010.Refer to the research in multi-dimensional AM-FM representations and also biomedical research projects for potential biomedical and general-purpose applications of the technology. Currently, the patent is available for licensing (including biomedical engineering applications).
The patent describes the development of robust methods for estimating AM-FM features from digital images. Biomedical applications were licensed to VisionQuest Biomedical, LLC. AM-FM representations have led to state of the art systems in computer aided diagnosis (CAD) in diabetic retinopathy image analysis, early prediction of advanced cases in multiple sclerosis, characterization of early atherosclerosis, and analysis of surface EMG signals. Refer to the research in multi-dimensional AM-FM representations and also biomedical research projects for more details. for several successful biomedical and general-purpose applications of the technology. Currently, the patent is available for licensing (including biomedical applications).